March 13, 2025
Mad Hedge Biotech and Healthcare Letter March 13, 2025 Fiat Lux Featured Trade: (THE 10,000 DAILY CONSULTATIONS YOU'LL NEVER SEE) (HIMS), (TDOC), (GDRX), (NVO), (LLY)
This author has not written his bio yet.
But we are proud to say that april@madhedgefundtrader.com contributed 2815 entries already.
Mad Hedge Biotech and Healthcare Letter March 13, 2025 Fiat Lux Featured Trade: (THE 10,000 DAILY CONSULTATIONS YOU'LL NEVER SEE) (HIMS), (TDOC), (GDRX), (NVO), (LLY)
Did you know that 100 years ago, the average American lifespan was just 54 years? Today, we're approaching 80. But what's truly remarkable isn't just that we're living longer—it's that a 36-year-old former Tinder executive named Andrew Dudum is revolutionizing how we access healthcare. His company, Hims & Hers (HIMS), has exploded from a niche
Global Market Comments March 13, 2025 Fiat Lux Featured Trade: (The Mad Hedge March traders & Investors Summit is ON!)
Markets are in freefall. Leaders like Tesla and Nvidia have already suffered massive losses. Are we headed for a recession or a Great Depression? What should you do about it? Attend the Mad Hedge Traders & Investors Summit on March 11-13. Learn from 24 of the best professionals in the market with decades of experience and
Mad Hedge Technology Letter March 12, 2025 Fiat Lux Featured Trade: (SHOULD I CARE ABOUT ORACLE?) (ORCL), (AAPL), (META), (AMZN)
If readers want to know if the Oracle AI story is dead or not, then listen here. The story is still alive, so don’t give up on a good thing. Oracle is getting swept up with the wider macroeconomic scare that has been triggered by geopolitics. The fear porn has reached fever pitch and is
“The key to making things affordable is design and technology improvements, as well as scale.” – Said Elon Musk
(THE POSSIBILITY OF A U.S. RECESSION IS NOW BEING ACKNOWLEDGED) March 12, 2025 Hello everyone The shift is on from bull to bear as the “R” word becomes a discussion topic. After a few months of me warning everyone about an impending down move/bear market, going against the grain of most professional analysts
Mad Hedge Biotech and Healthcare Letter March 11, 2025 Fiat Lux Featured Trade: (WHEN INSIDERS GO SHOPPING, PAY ATTENTION) (MRNA), (MRK)
In 1815, Nathan Rothschild made his legendary fortune buying British securities when they were deeply discounted after Waterloo. “Buy when there's blood in the streets,” he allegedly said. That kind of contrarian wisdom has made fortunes across centuries. Two centuries later, I find myself applying this timeless principle to Moderna (MRNA). The biotech darling has
Legal Disclaimer
There is a very high degree of risk involved in trading. Past results are not indicative of future returns. MadHedgeFundTrader.com and all individuals affiliated with this site assume no responsibilities for your trading and investment results. The indicators, strategies, columns, articles and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Affiliates of MadHedgeFundTrader.com may have a position or effect transactions in the securities described herein (or options thereon) and/or otherwise employ trading strategies that may be consistent or inconsistent with the provided strategies.